Scientists probe immune Cells' role in skin scarring disease
NCT ID NCT03559465
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how B cells, a type of immune cell, may contribute to scarring in people with systemic sclerosis (scleroderma). Researchers compared skin and blood samples from 71 participants, including patients and healthy volunteers. The goal was to understand the disease better, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCLERODERMA, SYSTEMIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Claude Huriez, CHU
Lille, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Are women with autoimmune diseases getting the gynecological care they need?
- New shot aims to tame rare autoimmune disease
- Cancer drug shows promise for rare skin disease
- Scientists probe immune Cells' role in scleroderma blood vessel injury
- New drug hope for scleroderma patients with lung complications
- New hope for scleroderma: arthritis drug tofacitinib tested against skin thickening